Donegan Michael C
SEC CIK 1627810 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TXMD | TherapeuticsMD, Inc. | Prin. Fin, Acctg. Off | 61.9K | — | $36.0K | 9 | 2021-11-30 | 2023-04-12 |
Most active insiders at TXMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thompson Tommy G | Dir | $14.0K | — |
Donegan Michael C made no open-market trades at TXMD in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | 2023-04-12 | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | Prin. Fin, Acctg. Off | M - OptEx | $0.00 | +50.0K | 61.9K | +422% | $0 |
| DM | 2023-01-30 | 2023-01-26 | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | Prin. Fin, Acctg. Off | M - OptEx | $0.00 | +5,940 | 13.6K | +78% | $0 |
| DM | 2023-01-30 | 2023-01-26+ | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | Prin. Fin, Acctg. Off | S - Sale+OE | $5.08 | -1,697 | 11.9K | -13% | -$8,621 |
| DM | 2023-01-25 | 2023-01-23 | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | Prin. Fin, Acctg. Off | M - OptEx | $0.00 | +4,365 | 6,519 | +203% | $0 |
| DM | 2023-01-25 | 2023-01-23+ | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | Prin. Fin, Acctg. Off | S - Sale+OE | $5.34 | -1,309 | 7,610 | -15% | -$6,990 |
| DM | 2022-12-09 | 2022-12-06 | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | CAO, Interim CFO, VP of Fin | M - OptEx | $0.00 | +3,476 | 4,288 | +428% | $0 |
| D | 2022-12-09 | 2022-12-06 | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | CAO, Interim CFO, VP of Fin | S - Sale+OE | $4.78 | -910 | 4,554 | -17% | -$4,350 |
| D | 2021-12-02 | 2021-11-30 | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | CAO, VP of Fin | S - Sale+OE | $0.54 | -29.8K | 99.4K | -23% | -$16.1K |
| D | 2021-12-02 | 2021-11-30 | TXMD | TherapeuticsMD, Inc. | Donegan Michael C | CAO, VP of Fin | M - OptEx | — | +115.0K | 129.2K | +812% | — |
Purchase Sale Sale after option exercise All abbreviations